Group 1: Global Gold Demand and Market Trends - In 2025, global gold demand is projected to reach 5002 tons, marking a historical high driven by geopolitical tensions and economic uncertainties, with total demand value reaching $555 billion in the previous year [1] - On January 29, international gold prices surged, with COMEX gold reaching $5626.8 per ounce and domestic gold jewelry prices exceeding 1700 yuan per gram, reflecting a significant daily increase [1] - The high gold prices have led to a booming gold recycling market, but also to consumer risks due to inflated quotes and other malpractices in the recycling process [1] Group 2: Banking and Financial Services - By December 2025, the wealth management scale of 11 national banks reached 13.46 trillion yuan, showing a 10% increase from the beginning of the year, despite a slight decline from November [2] - The growth in wealth management is attributed to a "deposit migration" trend, with Postal Savings Bank notably rising in ranking among the banks [2] Group 3: Technology and Manufacturing - The global AMOLED smartphone panel market is expected to see a shipment of approximately 920 million units in 2025, reflecting a 4.7% year-on-year growth, driven by demand for high-end smartphones [2] - The television industry is facing challenges due to rising costs in memory, panels, and precious metals, leading to a downward adjustment in expected global shipments for 2026 [2] Group 4: Corporate Developments - Tencent has had 499 million yuan worth of shares frozen due to legal proceedings involving Linzhi Tencent Technology Co., Ltd [6] - Suzhou Lianxun Instrument Co., Ltd has received approval from the China Securities Regulatory Commission for its IPO application on the Sci-Tech Innovation Board [7] - Runxin Micro Technology has completed nearly 400 million yuan in B+ round financing, aimed at enhancing its core technology capabilities [9] Group 5: Earnings Forecasts - Bai'ao Saitou expects a net profit of 162 million to 182 million yuan in 2025, representing a year-on-year increase of 384% to 444% [13] - Nanjing Mobi expects a net profit of 24 million to 34 million yuan in 2025, indicating a growth of 269.49% to 423.44% [14] - Jinko Power anticipates a net profit of 155 million to 195 million yuan in 2025, reflecting a growth of 383.21% to 507.9% [15]

Core Insights - New Oxygen announced multiple strategic initiatives, including the establishment of the Youth Selection Alliance with 14 upstream manufacturers and a strategic partnership with Sota [1][4] - The company received several prestigious certifications from Euromonitor International, including recognition for having the largest number of light medical beauty chain stores [5] Group 1: Strategic Initiatives - The Youth Selection Alliance aims to achieve win-win outcomes for upstream companies and consumers through collaboration in areas such as price-volume linkage, tiered supply, training, and product traceability [5] - New Oxygen's partnership with Sota includes a guarantee for the traceability of each Thermage treatment head, with a compensation policy for non-compliant equipment [5] Group 2: Supply Chain and Expansion - Since 2021, New Oxygen has invested 1 billion yuan in building its supply chain system, establishing 9 medical device sales companies and a network of 1 central warehouse and 8 forward warehouses across the country [5] - As of January 8, 2026, New Oxygen's clinics have achieved a cumulative treatment volume of 1 million across 50 stores in 16 cities [5] Group 3: Future Plans - The company plans to continue its conservative product selection strategy and launch multiple new products in the fields of phototherapy, water light, large injections, and health by 2026 [6] - New Oxygen aims to accelerate its offline expansion and recruitment of medical staff, with plans to add 35 new stores and increase the number of doctors to 500 and nursing staff to 1000 by the end of 2026 [6]

Core Viewpoint - The CEO of New Oxygen Group, Jin Xing, stated that the friction with upstream suppliers has not significantly impacted the company's business, despite some suppliers expressing concerns about the company's pricing strategy and product sourcing [1][2][6]. Group 1: Pricing Strategy and Market Impact - In September 2025, New Oxygen launched the "Youth Needle" product priced at 2999 yuan, which is significantly lower than the market price of over 10,000 yuan, disrupting the existing pricing structure of upstream manufacturers [1][6]. - Despite backlash from several upstream manufacturers, including claims of unauthorized product sourcing and training issues, sales of the "Youth Needle" reportedly surged in October, November, and December 2025, indicating strong consumer acceptance [2][6][7]. Group 2: Business Expansion and Partnerships - As of January 8, 2026, New Oxygen has established 50 clinics across 16 cities and achieved a cumulative treatment volume of 1 million [3][6]. - New Oxygen announced the formation of the "Youth Premium Alliance" with 14 upstream manufacturers, aiming to enhance collaboration through price-volume linkage, tiered supply, training, and product traceability [3][6]. Group 3: Industry Dynamics and Future Outlook - The medical beauty industry is experiencing a shift towards a buyer's market, with an increasing number of suppliers providing more options for medical institutions, which can now select long-term partners and customize products based on their needs [4][7]. - The industry has seen a significant increase in the issuance of medical device certifications, with 52 Class III medical device certificates issued in 2025, suggesting a growing supply landscape [4][7].

（编辑 姚尧） 证券日报网讯 1月28日，爱美客在互动平台回答投资者提问时表示，公司新品的终端销售、复购率、医 院进货数据等涉及商业和具体经营数据，公司未有单独的披露数据。公司严格按照法律法规的要求履行 信披义务。 ...

Group 1 - The company has received over 100,000 orders for its medical beauty dressing products since the launch of the Hainan Free Trade Port on December 18, 2025, indicating a significant demand surge [3] - The production facilities in Haikou National High-tech Zone are operating at full capacity to meet the order requirements, reflecting the company's commitment to fulfilling customer needs [3] - In 2025, the Haikou National High-tech Zone registered 6,068 new enterprises, representing a year-on-year growth of 106.5%, and 104 new foreign-funded enterprises, with a year-on-year increase of 131.1% [3]

来源丨 凤凰网《风暴眼》 作者丨 李小白 王天昱 网红的流量神话遇上公序良俗的红线，昔日靠魔性话术吸粉的 "性商教母"，终究迎来了全网声讨与渠道封停的结局。 只是这场看似彻底的崩塌背后，线下课程依旧隐秘运营，二手课程灰色交易暗流涌动，其 曾经的 商业版图里更藏着美容贷陷阱等诸多乱象。 网红经济的灰色地带，仍在这场风波中悄然涌动。 01 工作人员集体沉默，线下课还在继续 周媛 图源：网络 有人清空了全平台的视频内容，有人的内容更新停在 1月中旬，此后便再无动静。 周媛的所有社交账号，一夜之间没了踪迹。 1月22日，周媛的实名主账号率先被封禁，紧接着，其旗下"黑白颠严选"微信商城及一众关联账号均因违规被暂停访问，配套的线上课程系统也彻底 瘫痪，无法正常观看学习。 线上渠道被全面掐断，却并未让这套备受争议的课程体系彻底消失。 此前已有媒体报道，即便线上课程系统 "暂时修复中"，但黑白颠的线下课程，目前仍在正常开展。 只是这场整治风波，显然让黑白颠变得格外谨慎。 1月27日，凤凰网《风暴眼》以顾客身份，向"黑白颠"多名工作人员发送课程咨询 的 信 消息 ，始终无人回应。 而在其工作人员组建的粉丝群里发出的问询，同样石 ...

港股异动丨四环医药盘中涨8%，3日累计升幅约25%，近日童颜针新增规格获批上市 港股异动丨四环医 药涨超5% 童颜针新增规格获国家药监局批准上市 四环医药(0460.HK)盘中再度冲高至8%，3日累计升幅约25%，报1.58港元创逾3个月新低，总市值140亿 港元。 消息上，近日，四环医药发布公告，集团旗下渼颜空间生物科技(吉林)有限公司自主研发的聚乳 酸面部填充剂(市场简称"童颜针")6个新增规格正式获中国国家药品监督管理局批准，这是继该产品首 次获批后的又一重要进展，进一步完善了公司在再生医美产品领域的市场布局。 有分析称，四环医药 童颜针新增6个规格获批，是一次重要的产品迭代，对公司构成直接利好。其利好主要体现在产品能更 好地满足市场需求，从而提升竞争力与收入潜力。公司是国内唯一同时拥有合规"少女针"与"童颜针"两 大再生填充产品的企业。此举强化了其在再生医美领域的差异化竞争优势和产品矩阵。(格隆汇) 相关事件 ...

Group 1 - The core viewpoint of the article is that the company, Aimeike (300896), is actively managing its market value through a share repurchase plan amounting to 399 million yuan (excluding transaction costs) in 2023 [1] - The company emphasizes its commitment to market value management and will disclose any specific plans in accordance with relevant laws and regulations [1]

Core Insights - The latest 2025 public fund quarterly report reveals a significant shift in the top ten holdings of active equity funds, with technology and new energy stocks occupying nine positions, while only one position is held by Kweichow Moutai (600519) [1] Group 1: Market Trends - The change in top holdings reflects a divergence in the public consumption sector, where some funds continue to invest heavily in traditional consumer stocks, with certain liquor stocks being held for 36 consecutive quarters [1] - New consumption trends driven by collectibles, the millet economy, and medical beauty are gaining popularity among a new generation of fund managers [1]

Investment Rating - The report maintains a "Positive" outlook on the cosmetics and medical beauty industry, indicating strong performance compared to the market [2]. Core Insights - The cosmetics and medical beauty sector has outperformed the market recently, with the Shenwan Beauty Care Index rising by 2.0% from January 16 to January 23, 2026, surpassing the Shenwan A Index by 0.8 percentage points [4][5]. - December 2025 saw a significant increase in social retail sales for cosmetics, reaching 38 billion yuan, with a growth rate of 8.8%, indicating robust demand even in the off-season. The overall growth rate for Q4 was 9.9%, significantly higher than the annual growth of 5.1% for 2025, driven by promotional events like Double 11 [10][17]. - The report anticipates continued high consumer demand in Q1 2026, supported by new product launches and regulatory approvals in the medical beauty sector [10]. Summary by Sections Industry Performance - The cosmetics and medical beauty sector has shown strong performance, with the Shenwan Cosmetics Index increasing by 2.6% and the Shenwan Personal Care Index rising by 4.2%, both outperforming the Shenwan A Index [4][5]. Key Company Reviews - Lin Qingxuan (2657HK) is highlighted as a benchmark in the high-end domestic skincare market, with revenue projected to grow from 690 million yuan in 2022 to 1.21 billion yuan in 2024, representing a CAGR of 32.7%. The company is expected to turn a profit of 187 million yuan in 2024, a 120% increase year-on-year [11][12]. - Langzi Co., Ltd. (002612.SZ) forecasts a net profit of 900 million to 1.05 billion yuan for 2025, reflecting a year-on-year growth of 245.25% to 302.80% [4]. - Qingsong Co., Ltd. (300132.SZ) anticipates a net profit of 130 million to 165 million yuan for 2025, with a growth rate of 137.73% to 201.74% [4]. Market Trends - The report notes that the high-end skincare market is expanding, with the market size expected to reach 218.5 billion yuan by 2029. The concept of "oil-based skincare" is becoming mainstream, driving growth in the facial oil segment, which is projected to grow at a CAGR of 42.8% from 2019 to 2024 [12][14]. - E-commerce channels are increasingly important, with Lin Qingxuan achieving a 65.4% online revenue share in H1 2025, leveraging platforms like Douyin and Tmall for growth [13]. Sales Data - In December 2025, the total retail sales of cosmetics reached 38 billion yuan, with a year-on-year growth of 8.8%. The overall retail sales for cosmetics in 2025 were 465.3 billion yuan, reflecting a 5.1% increase [17][21].